Increases in the number of cancer cases being diagnosed and treated likely will drive cost trends for antineoplastic enzyme inhibitors.
Tamra Wade
Advertisement
Articles by Tamra Wade
The proportion of Americans diagnosed with Alzheimer's disease (AD) is projected to increase almost 2-fold over the next couple of decades due to size of the Baby Boom generation compared with the total US population.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
2
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
3
Comprehensive Lancet Review Reaffirms Safety, Effectiveness of mRNA Vaccines
4
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
5